Vanguard Group Inc Terns Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,356,814 shares of TERN stock, worth $19.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,356,814
Previous 2,300,942 45.89%
Holding current value
$19.1 Million
Previous $15.7 Million 78.66%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$6.49 - $10.8 $6.85 Million - $11.4 Million
1,055,872 Added 45.89%
3,356,814 $28 Million
Q2 2024

Aug 13, 2024
BUY
$4.54 - $8.2 $462,789 - $835,875
101,936 Added 4.64%
2,300,942 $15.7 Million
Q1 2024

May 10, 2024
BUY
$4.86 - $8.19 $56,060 - $94,471
11,535 Added 0.53%
2,199,006 $14.4 Million
Q4 2023

Feb 14, 2024
SELL
$3.37 - $6.86 $49,346 - $100,450
-14,643 Reduced 0.66%
2,187,471 $14.2 Million
Q3 2023

Nov 14, 2023
SELL
$4.7 - $8.55 $108,837 - $197,992
-23,157 Reduced 1.04%
2,202,114 $11.1 Million
Q2 2023

Aug 14, 2023
BUY
$7.35 - $13.29 $6.87 Million - $12.4 Million
934,022 Added 72.33%
2,225,271 $19.5 Million
Q1 2023

May 15, 2023
BUY
$7.91 - $12.0 $1.31 Million - $1.98 Million
165,213 Added 14.67%
1,291,249 $15.3 Million
Q4 2022

Feb 10, 2023
BUY
$4.62 - $10.18 $2.34 Million - $5.16 Million
506,904 Added 81.87%
1,126,036 $11.5 Million
Q3 2022

Nov 14, 2022
BUY
$1.87 - $6.42 $470,497 - $1.62 Million
251,603 Added 68.46%
619,132 $3.65 Million
Q2 2022

Aug 12, 2022
SELL
$1.5 - $3.0 $98,235 - $196,470
-65,490 Reduced 15.12%
367,529 $912,000
Q1 2022

May 13, 2022
SELL
$2.83 - $6.7 $354,621 - $839,563
-125,308 Reduced 22.44%
433,019 $1.29 Million
Q4 2021

Feb 14, 2022
BUY
$5.65 - $10.73 $664,750 - $1.26 Million
117,655 Added 26.7%
558,327 $3.95 Million
Q3 2021

Nov 12, 2021
BUY
$7.22 - $13.46 $180,081 - $335,719
24,942 Added 6.0%
440,672 $4.59 Million
Q2 2021

Aug 13, 2021
BUY
$12.26 - $22.0 $5.1 Million - $9.15 Million
415,730 New
415,730 $5.1 Million

Others Institutions Holding TERN

# of Institutions
167
Shares Held
78.3M
Call Options Held
580K
Put Options Held
454K
View Full List

About Terns Pharmaceuticals, Inc.

TERN Quotes by TradingView
  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $214M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email